Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 9;26(7):601–608. doi: 10.1177/1753425920942580

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 4. — Comparison of NK cells in the R group and age-, sex- and treatment course–matched NR group during PEG-IFN treatment. Comparison of NK cell levels between those who achieved HBsAg seroconversion after 48 wk of treatment (R group; n = 15) and those who failed to achieve HBsAg seroconversion (NR group; n = 15) at the time point before HBsAg seroconversion was detected (Pre-P) and at the time point when seroconversion of HBsAg was detected (Post-P) after matching for age, sex and course of treatment.